Surgery Partners, Inc. (SGRY) Tops Q2 EPS by 20c

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of $0.28, $0.20 better than the analyst estimate of $0.08. Revenue for the quarter came in at $667.6 million versus the consensus estimate of $669.47 million.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
• Morgan Stanley Upgrades M&T Bank (MTB) to Overweight